Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Factors Predicting Patient's Allocation to Short- and Long-Term Therapeutic Community Treatments in the Italian VOECT Cohort Study.

Vigna-Taglianti F, Mathis F, Diecidue R, Trogu E, Kirchmayer U, Ghibaudi J, Piras G, Camposeragna A, Saponaro A, Amato L, Davoli M, Faggiano F, Pani PP; VOECT Study Group..

Community Ment Health J. 2017 Feb 8. doi: 10.1007/s10597-017-0105-z. [Epub ahead of print]

PMID:
28181094
2.

Low carbohydrate diet prevents Mcl-1-mediated resistance to BH3-mimetics.

Rubio-Patiño C, Bossowski JP, Villa E, Mondragón L, Zunino B, Proïcs E, Chiche J, Bost F, Verhoeyen E, Ricci JE.

Oncotarget. 2016 Nov 8;7(45):73270-73279. doi: 10.18632/oncotarget.12309.

3.

Hyperthermic intra-peritoneal chemotherapy and anticancer immune response.

Zunino B, Ricci JE.

Oncoimmunology. 2015 Jul 15;5(1):e1060392. eCollection 2016.

4.

In-situ photo-assisted deposition of silver particles on hydrogel fibers for antibacterial applications.

Raho R, Paladini F, Lombardi FA, Boccarella S, Zunino B, Pollini M.

Mater Sci Eng C Mater Biol Appl. 2015 Oct;55:42-9. doi: 10.1016/j.msec.2015.05.050. Epub 2015 May 21.

PMID:
26117737
5.

The theoretical model of the school-based prevention programme Unplugged.

Vadrucci S, Vigna-Taglianti FD, van der Kreeft P, Vassara M, Scatigna M, Faggiano F, Burkhart G; EU-Dap Study Group..

Glob Health Promot. 2016 Dec;23(4):49-58. Epub 2015 Jun 10.

PMID:
26062869
6.

Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90.

Zunino B, Rubio-Patiño C, Villa E, Meynet O, Proics E, Cornille A, Pommier S, Mondragón L, Chiche J, Bereder JM, Carles M, Ricci JE.

Oncogene. 2016 Jan 14;35(2):261-8. doi: 10.1038/onc.2015.82. Epub 2015 Apr 13.

PMID:
25867070
7.

GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.

Chiche J, Pommier S, Beneteau M, Mondragón L, Meynet O, Zunino B, Mouchotte A, Verhoeyen E, Guyot M, Pagès G, Mounier N, Imbert V, Colosetti P, Goncalvès D, Marchetti S, Brière J, Carles M, Thieblemont C, Ricci JE.

Leukemia. 2015 May;29(5):1163-76. doi: 10.1038/leu.2014.324. Epub 2014 Nov 14.

PMID:
25394713
8.

Glucose metabolism is inhibited by caspases upon the induction of apoptosis.

Pradelli LA, Villa E, Zunino B, Marchetti S, Ricci JE.

Cell Death Dis. 2014 Sep 4;5:e1406. doi: 10.1038/cddis.2014.371.

9.

"Unplugged," a European school-based program for substance use prevention among adolescents: overview of results from the EU-Dap trial.

Vigna-Taglianti FD, Galanti MR, Burkhart G, Caria MP, Vadrucci S, Faggiano F; EU-Dap Study Group..

New Dir Youth Dev. 2014 Spring;2014(141):67-82, 11-2. doi: 10.1002/yd.20087.

PMID:
24753279
10.

Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice.

Meynet O, Zunino B, Happo L, Pradelli LA, Chiche J, Jacquin MA, Mondragón L, Tanti JF, Taillan B, Garnier G, Reverso-Meinietti J, Mounier N, Michiels JF, Michalak EM, Carles M, Scott CL, Ricci JE.

Blood. 2013 Oct 3;122(14):2402-11. doi: 10.1182/blood-2013-01-478651. Epub 2013 Aug 21.

11.

GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death.

Jacquin MA, Chiche J, Zunino B, Bénéteau M, Meynet O, Pradelli LA, Marchetti S, Cornille A, Carles M, Ricci JE.

Cell Death Differ. 2013 Aug;20(8):1043-54. doi: 10.1038/cdd.2013.32. Epub 2013 May 3.

12.

Classroom characteristics and implementation of a substance use prevention curriculum in European countries.

Caria MP, Faggiano F, Bellocco R, Galanti MR; EU-Dap Study Group..

Eur J Public Health. 2013 Dec;23(6):1088-93. doi: 10.1093/eurpub/cks191. Epub 2013 Jan 18.

PMID:
23334820
13.

Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response.

Bénéteau M, Zunino B, Jacquin MA, Meynet O, Chiche J, Pradelli LA, Marchetti S, Cornille A, Carles M, Ricci JE.

Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20071-6. doi: 10.1073/pnas.1206360109. Epub 2012 Nov 19.

14.

Effects of a school-based prevention program on European adolescents' patterns of alcohol use.

Caria MP, Faggiano F, Bellocco R, Galanti MR; EU-Dap Study Group..

J Adolesc Health. 2011 Feb;48(2):182-8. doi: 10.1016/j.jadohealth.2010.06.003.

PMID:
21257118
15.

The effectiveness of a school-based substance abuse prevention program: 18-month follow-up of the EU-Dap cluster randomized controlled trial.

Faggiano F, Vigna-Taglianti F, Burkhart G, Bohrn K, Cuomo L, Gregori D, Panella M, Scatigna M, Siliquini R, Varona L, van der Kreeft P, Vassara M, Wiborg G, Galanti MR; EU-Dap Study Group..

Drug Alcohol Depend. 2010 Apr 1;108(1-2):56-64. doi: 10.1016/j.drugalcdep.2009.11.018. Epub 2010 Jan 18.

PMID:
20080363
16.

Is universal prevention against youths' substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial.

Vigna-Taglianti F, Vadrucci S, Faggiano F, Burkhart G, Siliquini R, Galanti MR; Eu-Dap Study Group..

J Epidemiol Community Health. 2009 Sep;63(9):722-8. doi: 10.1136/jech.2008.081513. Epub 2009 Apr 23.

PMID:
19395396
17.

The effectiveness of a school-based substance abuse prevention program: EU-Dap cluster randomised controlled trial.

Faggiano F, Galanti MR, Bohrn K, Burkhart G, Vigna-Taglianti F, Cuomo L, Fabiani L, Panella M, Perez T, Siliquini R, van der Kreeft P, Vassara M, Wiborg G; EU-Dap Study Group..

Prev Med. 2008 Nov;47(5):537-43. doi: 10.1016/j.ypmed.2008.06.018. Epub 2008 Jul 9.

PMID:
18657569

Supplemental Content

Loading ...
Support Center